FN2 Earnings Intelligence
The Clorox Company income statement (quarterly)
The Clorox Company (CLX) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $290 | $226 | $166 | $227 | $1,187 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $1,686 | $1,668 | $1,429 | $1,673 | $1,670 | $1,914.9 | $1,828.1 |
| % Growth | - | - | - | - | - | - | 27.9% |
| Gross Profit | $738 | $744 | $596 | $722 | $722 | - | - |
| % Margin | 43.8% | 44.6% | 41.7% | 43.2% | 43.2% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $193 | $186 | $80 | $157 | $187 | - | - |
| % Margin | 11.4% | 11.2% | 5.6% | 9.4% | 11.2% | - | - |
| Diluted EPS | $1.54 | $1.50 | $0.65 | $1.29 | $1.54 | $1.64 | $1.17 |
| % Growth | - | - | - | - | - | - | 80.6% |
| Operating Cash Flow | - | - | $93 | - | - | - | - |
| CapEx | - | - | $36 | - | - | - | - |
| Free Cash Flow | - | - | $57 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $1,686 | $1,668 | $1,429 | $1,673 | $1,670 | $1,914.9 | $1,828.1 |
| Gross Profit | $738 | $744 | $596 | $722 | $722 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $193 | $186 | $80 | $157 | $187 | - | - |
| Diluted EPS | $1.54 | $1.50 | $0.65 | $1.29 | $1.54 | $1.64 | $1.17 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $290 | $226 | $166 | $227 | $1,187 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $2,483 | $2,483 | $2,485 | $2,486 | $2,487 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $93 | - | - |
| Capital Expenditure | - | - | $36 | - | - |
| Free Cash Flow | - | - | $57 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 43.8% | 44.6% | 41.7% | 43.2% | 43.2% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 11.4% | 11.2% | 5.6% | 9.4% | 11.2% |
| FCF Margin | - | - | 4.0% | - | - |
| Diluted EPS Growth | - | - | - | - | - |